The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases

心脏、肺、血液和睡眠疾病护理点推进中心

• 批准号: 10222761
• 负责人: BRYAN O BUCHHOLZ
• 金额: $ 156.25万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-08-22 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10222761
• 关键词: Address; Adoption; Affect; American; Automobile Driving; Blood; Businesses; Cardiovascular system; Caregivers; Caring; Cessation of life; Clinic; Clinical; Detection; Development; Device or Instrument Development; Diagnosis; Disease; Engineering; Family Caregiver; Feedback; Funding; Goals; Health; Healthcare; Heart; Heart Diseases; Heart failure; Hematological Disease; Income; Incubators; Intervention; Knowledge; Lead; Life; Lung; Lung diseases; Massachusetts; Medical; Medical Device; Mentors; Modeling; Monitor; Morbidity - disease rate; Outpatients; Participant; Pathway interactions; Patients; Physicians; Point of Care Technology; Policy Maker; Preventive measure; Process; Provider; Quality of life; Reporting; Resources; Role; Self Care; Sleep; Sleep Disorders; Symptoms; System; Technology; Time; Training; Training Programs; Universities; Vision; acute care; bundled payment; clinical development; commercialization; cost; evidence base; hospital readmission; hypertension control; improved; industry partner; medical schools; mortality; novel; point of care; precision medicine; programs; research clinical testing; success; technology development; tool; trend; user-friendly

PROJECT SUMMARY/ABSTRACT - OVERALL American healthcare is rapidly evolving to a state where efficiency and quality in health care are co-dominant drivers. Several emergent trends are driving fundamental changes in health care: 1) increasing numbers of patients in accountable care organizations with bundled payments to providers; 2) emphasis on quality metrics such as reducing readmissions for heart failure and improving control of hypertension; and 3) increasing focus on the patient as a driver of medical decisions and a partner in care. There is now an urgent need to develop technologies that provide rapid feedback to both caregivers and patients in order to effect timely changes in patient self-care, symptom detection, diagnosis and treatment delivery. In particular, there is a critical need for new evidence-based, user-friendly, patient-centric, point-of-care technologies (POCT) to monitor health/medical status in people as they go about their daily lives out of the clinic and to deliver actionable reports to the point of care. The Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Diseases will be an offshoot of a highly successful medical product incubator, the Massachusetts Medical Device Development Center (M2D2) at the University of Massachusetts (Lowell and Worcester campuses). The founding goal of M2D2 was to accelerate the development of medical devices, using the combined expertise of UMass Lowell (UML) in engineering and business, and the clinical expertise of UMass Medical School (UMMS) in Worcester. Expanding upon the vision and success of M2D2, the goal of CAPCaT is to develop and optimize novel POCT to improve the diagnosis and management of heart, lung, blood and sleep (HLBS) diseases. We have focused on these diseases because of the significant morbidity, mortality, and cost associated with these diseases. Combined, these diseases account for 41% of deaths in the US and lead to over $400B in direct health care expenses plus lost income to affected patients and caregivers. UMass has an established track record of clinical expertise and technology development in the HLBS diseases. Our objectives are to: 1) identify, through stakeholder engagement, the most promising POCTs to address unmet medical needs; 2) support developmental plans, including pathways to adoption at the point of care; and 3) train and disseminate developing POCT to the different stakeholders.

项目摘要/摘要 - 总体 美国的医疗保健正在迅速发展到医疗保健效率和质量的状态 共同主导的驾驶员。几种紧急趋势正在推动医疗保健的根本变化： 1）在负责任的护理组织中增加了捆绑付款的患者 提供者； 2）强调质量指标，例如减少心力衰竭和 改善对高血压的控制； 3）越来越关注患者作为医疗司机 决策和护理伙伴。现在迫切需要开发技术 向护理人员和患者提供快速反馈，以及时改变 患者自我保健，症状检测，诊断和治疗分娩。特别是有一个 对新的基于循证的，用户友好，以患者为中心的护理点技术的批判需求 （POCT）监视人们的健康/医疗状况，因为他们从事日常生活 诊所并提供可行的报告到护理点。前进的中心 心脏，肺，血液和睡眠疾病的护理技术（CAPCAT）将是 马萨诸塞州医疗设备开发非常成功的医疗产品孵化器 马萨诸塞大学（Lowell和Worcester校园）的中心（M2D2）。这 M2D2的创建目标是加速医疗设备的开发 UMass Lowell（UML）在工程和业务中的联合专业知识以及临床 伍斯特UMass医学院（UMMS）的专业知识。扩大愿景和 M2D2的成功，CAPCAT的目标是开发和优化新颖的POCT以改善 心脏，肺，血液和睡眠（HLB）疾病的诊断和管理。我们专注于 由于这些疾病的发病率，死亡率和成本很大，因此 疾病。这些疾病合并占美国死亡的41％，并导致结束 $ 400B的直接医疗保健费用以及受影响的患者和护理人员的收入损失。 UMass在 HLBS疾病。我们的目标是：1）通过利益相关者的参与确定最多的目标 有希望的POCT可以满足未满足的医疗需求； 2）支持发展计划，包括 在护理点领养的途径； 3）训练和传播开发POCT 不同的利益相关者。